Clinical Trials in Seattle

Showing 1021-1040 of 8,049 trials

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

NCT04969835

This is a first-in-human (FIH), Phase 1 open-label, multicentre dose escalation study investigating AVA6000 monotherapy administered intravenously in patients with locally advanced (unresectable) or metastatic solid tumours that are likely to be FAP positive. The study consists of an initial Phase 1a dose escalation portion and a subsequent Phase 1b dose expansion portion upon completion of the dose escalation portion.

Salivary Gland TumorUrothelial CarcinomaOvarian Carcinoma+2 more

Avacta Life Sciences Ltd158 participantsStarted Jul 2021

New York, New York, United States • Houston, Texas, United States • Seattle, Washington, United States +6 more locations

Active Not RecruitingPhase 2< 1 mile

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

NCT03808662

The purpose of this study is determine if receiving stereotactic body radiation(SBRT) when participants' metastatic tumors have just begun to grow increase the length of time before disease gets worse

TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more

Memorial Sloan Kettering Cancer Center107 participantsStarted Jan 2019

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +7 more locations

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Find Trials by Condition in Seattle

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

I-DECIDE After Bronchiolitis Hospitalization

Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

Micra AV Transcatheter Pacing System Post-Approval Registry

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases